STIM
Neuronetics, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
+8/100
Last price
2.19
▼ 0.02 (0.90%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2.22
Prev close
2.21
Day high
2.23
Day low
2.15
Volume
637.66K
Market cap
$165.35M
P/E (TTM)
—
52W range
0.80 – 3.44
Day trading desk
Gap from prior close
+0.45%
Prior close 2.21
VWAP
2.19
-0.20% from price
Relative volume
0.31×
Quiet session
Session range
3.25%
2.15 – 2.22
Position in range
50%
Mid range
ATR (14D)
0.14
6.52% of price
Prior day high
2.28
PDH
Prior day low
2.19
PDL
Bid / ask spread
—
Quote not published
Session volume
637.58K
Avg 2.08M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.26%
-9.2%
1M
-25.94%
-27.4%
3M
+30.72%
+27.3%
6M
+43.71%
+28.7%
YTD
+57.25%
+43.3%
1Y
-23.32%
-39.0%
3Y
+65.65%
-16.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on STIM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+1.50M
Net buying
Buy transactions
12
1.51M shares
Sell transactions
1
8.57K shares
Net transactions
+13
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
23.53M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 14.00K | $44.24K | Direct |
| Jul 23, 26 | NAOR NIR Chief Financial Officer |
STOCK | 500.00K | $0 | Direct |
| Jul 14, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 35.00K | $62.30K | Direct |
| May 28, 26 | MUIR GLENN P Director |
STOCK | 30.00K | $0 | Direct |
| May 28, 26 | CASCELLA ROBERT A Director |
STOCK | 36.25K | $0 | Direct |
| May 28, 26 | CONLEY SHERYL L Director |
STOCK | 30.00K | $0 | Direct |
| May 28, 26 | ROSENGARTEN MEGAN Director |
STOCK | 30.00K | $0 | Direct |
| May 28, 26 | CUCUZ SASHA Director |
STOCK | 30.00K | $0 | Direct |
| May 28, 26 | AMIN AVINASH N. M.D. Director |
STOCK | 30.00K | $0 | Direct |
| May 19, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 100.00K | $117.00K | Direct |
| May 12, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 475.00K | $636.50K | Direct |
| Apr 21, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 200.00K | $309.00K | Direct |
| Mar 30, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 385.44K | $481.80K | Direct |
| Mar 27, 26 | CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security |
BUY | 500.00K | $675.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CASCELLA ROBERT A |
Director | 625.02K | Stock Award(Grant) |
CHERNETT JOREY |
Beneficial Owner of more than 10% of a Class of Security | 10.60M | Purchase |
CUCUZ SASHA |
Director | 2.06M | Stock Award(Grant) |
FURLONG STEPHEN |
Chief Financial Officer | 410.05K | Sale |
MACAN WILLIAM ANDREW |
Officer | 897.27K | Sale |
MADRYN ASSET MANAGEMENT, LP |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
NAOR NIR |
Chief Financial Officer | 500.00K | Stock Award(Grant) |
PFANSTIEL STEVEN |
Officer | 836.64K | Sale |
REUVERS DANIEL L |
Chief Executive Officer | 1.50M | Stock Award(Grant) |
SULLIVAN KEITH J |
Former | 1.59M | Sale |
Fundamentals
Market cap$165.35M
Enterprise value$239.51M
Revenue (TTM)$155.10M
Gross profit$76.59M
EBITDA$-19.26M
Net income$-30.43M
EPS (TTM)$-0.43
Free cash flow$345.63K
Total cash$19.20M
Total debt$86.52M
Book value / share$0.23
Shares outstanding76.20M
Float37.15M
Short % of float15.16%
Dividend yield0.00%
Beta (5Y)1.20
Valuation & profitability ratios
Trailing P/E—
Forward P/E-6.38
PEG ratio—
Price / sales—
Price / book9.27
EV / revenue1.54
EV / EBITDA-12.43
Gross margin49.38%
Operating margin-3.61%
Profit margin-19.62%
Return on equity-116.10%
Return on assets-10.55%
Debt / equity399.83
Current ratio1.88
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $149.16M | $74.89M | $71.35M | $65.21M | +99.2% |
| Operating revenue | $149.16M | $74.89M | $71.35M | $65.21M | +99.2% |
| Cost of revenue | $76.85M | $20.73M | $19.64M | $15.48M | +270.7% |
| Gross profit | $72.31M | $54.16M | $51.70M | $49.72M | +33.5% |
| Research & development | $6.58M | $12.77M | $9.52M | $9.34M | -48.4% |
| Selling, general & admin | $97.16M | $75.95M | $72.74M | $75.50M | +27.9% |
| Total operating expense | $103.74M | $88.72M | $82.26M | $84.83M | +16.9% |
| Operating income | -$31.44M | -$34.56M | -$30.55M | -$35.11M | +9.0% |
| Net interest income | -$8.40M | -$7.30M | -$5.40M | -$4.30M | -15.1% |
| Pre-tax income | -$39.12M | -$43.74M | -$30.16M | -$37.21M | +10.6% |
| Net income | -$39.00M | -$43.71M | -$30.19M | -$37.16M | +10.8% |
| Net income to common | -$39.00M | -$43.71M | -$30.19M | -$37.16M | +10.8% |
| Basic EPS | -0.59 | -1.37 | -1.05 | -1.38 | +56.9% |
| Diluted EPS | -0.59 | -1.37 | -1.05 | -1.38 | +56.9% |
| EBIT | -$31.52M | -$37.24M | -$25.36M | -$33.61M | +15.4% |
| EBITDA | -$28.05M | -$35.17M | -$23.36M | -$31.96M | +20.2% |
| Basic shares | 65.95M | 31.63M | 28.66M | 26.90M | +108.5% |
| Diluted shares | 65.95M | 31.63M | 28.66M | 26.90M | +108.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $28.13M | $18.46M | $59.68M | $70.34M | +52.4% |
| Cash & short-term investments | $28.36M | $18.66M | $60.58M | $71.88M | +51.9% |
| Accounts receivable | $16.47M | $23.36M | $15.78M | $13.59M | -29.5% |
| Inventory | $4.33M | $4.25M | $8.09M | $8.90M | +1.9% |
| Total current assets | $61.55M | $58.12M | $93.79M | $98.77M | +5.9% |
| Property, plant & equipment | $28.03M | $33.34M | $4.78M | $5.32M | -15.9% |
| Goodwill & intangibles | $41.77M | $38.24M | $0 | — | +9.2% |
| Total assets | $141.55M | $140.90M | $115.83M | $116.88M | +0.5% |
| Total current liabilities | $30.52M | $31.27M | $19.81M | $33.20M | -2.4% |
| Current debt | — | — | — | $13.13M | — |
| Long-term debt | $65.81M | $55.15M | $59.28M | $22.83M | +19.3% |
| Total debt | $90.30M | $82.63M | $62.47M | $39.74M | +9.3% |
| Total liabilities | $115.31M | $109.10M | $81.64M | $59.82M | +5.7% |
| Retained earnings | -$458.79M | -$419.79M | -$376.08M | -$345.89M | -9.3% |
| Shareholder equity | $22.38M | $27.71M | $34.19M | $57.06M | -19.2% |
| Working capital | $31.03M | $26.86M | $73.98M | $65.57M | +15.5% |
| Net tangible assets | -$19.39M | -$10.53M | $34.19M | $57.06M | -84.1% |
| Shares issued | 68.99M | 55.68M | 29.09M | 27.27M | +23.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$39.13M | -$43.73M | -$30.19M | -$37.16M | +10.5% |
| Depreciation & amortisation | $3.46M | $2.07M | $2.01M | $1.65M | +67.1% |
| Stock-based compensation | $6.85M | $5.60M | $7.32M | $8.75M | +22.2% |
| Change in working capital | $6.58M | -$6.81M | -$14.10M | -$5.12M | +196.6% |
| Operating cash flow | -$20.37M | -$31.00M | -$32.04M | -$30.74M | +34.3% |
| Capital expenditure | -$801.00K | -$1.47M | -$2.37M | -$3.27M | +45.4% |
| Investing cash flow | -$801.00K | -$2.41M | -$1.32M | $6.73M | +66.8% |
| Share buybacks | -$1.73M | $0 | $0 | — | — |
| Financing cash flow | $35.85M | -$6.81M | $22.70M | $207.00K | +626.6% |
| Free cash flow | -$21.18M | -$32.46M | -$34.41M | -$34.01M | +34.8% |
| End cash position | $34.13M | $19.46M | $59.68M | $70.34M | +75.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $41.57M | $34.45M | $41.78M | $37.30M | $38.11M | +20.6% |
| Operating revenue | $41.57M | $34.45M | $41.78M | $37.30M | $38.11M | +20.6% |
| Cost of revenue | $20.34M | $18.30M | $20.07M | $20.19M | $20.35M | +11.2% |
| Gross profit | $21.22M | $16.15M | $21.70M | $17.11M | $17.76M | +31.4% |
| Research & development | $1.34M | $1.36M | $1.67M | $1.50M | $1.80M | -2.1% |
| Selling, general & admin | $21.39M | $23.79M | $25.08M | $22.93M | $24.02M | -10.1% |
| Total operating expense | $22.72M | $25.15M | $26.75M | $24.43M | $25.82M | -9.6% |
| Operating income | -$1.50M | -$8.99M | -$5.04M | -$7.32M | -$8.06M | +83.3% |
| Net interest income | -$2.10M | -$2.30M | -$2.30M | -$2.20M | -$2.00M | +8.7% |
| Pre-tax income | -$3.44M | -$10.81M | -$7.19M | -$9.39M | -$9.87M | +68.2% |
| Net income | -$3.44M | -$10.79M | -$7.16M | -$9.04M | -$10.12M | +68.1% |
| Net income to common | -$3.44M | -$10.79M | -$7.16M | -$9.04M | -$10.12M | +68.1% |
| Basic EPS | -0.05 | -0.16 | -0.10 | -0.13 | -0.15 | +68.8% |
| Diluted EPS | -0.05 | -0.16 | -0.10 | -0.13 | -0.15 | +68.8% |
| EBIT | -$1.54M | -$8.81M | -$5.09M | -$7.39M | -$8.07M | +82.5% |
| EBITDA | -$810.00K | -$8.07M | -$4.32M | -$6.51M | -$7.17M | +90.0% |
| Basic shares | 73.13M | 69.59M | 68.76M | 67.31M | 66.18M | +5.1% |
| Diluted shares | 73.13M | 69.59M | 68.76M | 67.31M | 66.18M | +5.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.20M | $13.21M | $28.13M | $27.97M | $10.97M | +45.3% |
| Cash & short-term investments | $19.43M | $13.47M | $28.36M | $28.15M | $11.14M | +44.2% |
| Accounts receivable | $15.96M | $15.81M | $16.47M | $18.69M | $26.12M | +0.9% |
| Inventory | $5.50M | $4.71M | $4.33M | $4.32M | $4.94M | +16.7% |
| Total current assets | $53.23M | $47.17M | $61.55M | $64.89M | $56.14M | +12.8% |
| Property, plant & equipment | $27.38M | $26.94M | $28.03M | $29.17M | $29.80M | +1.6% |
| Goodwill & intangibles | $41.04M | $41.41M | $41.77M | $41.18M | $37.96M | -0.9% |
| Total assets | $131.53M | $125.44M | $141.55M | $145.47M | $134.65M | +4.9% |
| Total current liabilities | $28.31M | $28.29M | $30.52M | $28.94M | $27.80M | +0.1% |
| Long-term debt | $61.52M | $61.30M | $65.81M | $65.67M | $55.54M | +0.4% |
| Total debt | $86.52M | $85.39M | $90.30M | $90.75M | $80.66M | +1.3% |
| Total liabilities | $109.89M | $108.38M | $115.31M | $114.11M | $103.14M | +1.4% |
| Retained earnings | -$473.15M | -$469.58M | -$458.79M | -$451.63M | -$442.58M | -0.8% |
| Shareholder equity | $17.85M | $13.27M | $22.38M | $27.36M | $27.15M | +34.6% |
| Working capital | $24.92M | $18.89M | $31.03M | $35.95M | $28.34M | +31.9% |
| Net tangible assets | -$23.19M | -$28.14M | -$19.39M | -$13.82M | -$10.81M | +17.6% |
| Shares issued | 76.19M | 69.58M | 68.99M | 68.44M | 66.11M | +9.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$3.46M | -$10.78M | -$7.21M | -$9.40M | -$9.84M | +67.9% |
| Depreciation & amortisation | $729.00K | $745.00K | $767.00K | $886.00K | $901.00K | -2.1% |
| Stock-based compensation | $688.00K | $1.68M | $2.18M | $1.41M | $1.81M | -59.0% |
| Change in working capital | $581.00K | -$1.83M | $4.59M | $5.72M | $3.12M | +131.7% |
| Operating cash flow | -$1.01M | -$9.42M | $908.00K | -$785.00K | -$3.50M | +89.3% |
| Capital expenditure | -$417.00K | -$197.00K | -$216.00K | -$114.00K | -$252.00K | -111.7% |
| Investing cash flow | -$417.00K | -$172.00K | -$216.00K | -$114.00K | -$252.00K | -142.4% |
| Financing cash flow | $7.41M | -$5.58M | -$1.03M | $17.90M | $1.00K | +232.8% |
| Free cash flow | -$1.43M | -$9.62M | $692.00K | -$899.00K | -$3.76M | +85.2% |
| End cash position | $24.95M | $18.96M | $34.13M | $34.47M | $17.47M | +31.5% |
Options analytics
Put / call volume
0.67
Call-heavy session
Put / call open interest
2.17
Positioning, not flow
Max pain
2.50
+15.2% from spot
ATM implied vol
167.2%
Nearest strike to spot
Skew (10% OTM)
-89.1%
Calls bid over puts
Call volume
3
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
2.50
59 contracts
Heaviest put OI
2.50
182 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.12 | -0.04 | +65.1% |
| Mar 2026 | -0.17 | -0.15 | +15.0% |
| Dec 2025 | -0.11 | -0.10 | +9.1% |
| Sep 2025 | -0.12 | -0.13 | -8.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.11 | 1 | $40.42M | +8.4% |
| Next quarter | -0.07 | 1 | $45.60M | +9.2% |
| Current year | -0.47 | 1 | $162.03M | +8.6% |
| Next year | -0.34 | 1 | $177.00M | +9.2% |
Analyst targets & ownership
Mean target$5.75
High target$7.00
Low target$5.00
Implied upside162.56%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy1 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders30.88%
Held by institutions54.00%
Institutions holding105
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.38
-7.89% from price
SMA 20
2.64
-17.79% from price
SMA 50
2.71
-19.83% from price
SMA 100
2.08
+5.06% from price
SMA 200
1.83
+18.47% from price
EMA 12
2.40
-8.87% from price
EMA 26
2.56
-14.56% from price
EMA 50
2.52
-13.04% from price
RSI (14)
30.8
Neutral
MACD (12,26,9)
-0.16
Hist -0.08
ATR (14)
0.14
6.58% of price
Realised vol 30D
51.0%
Annualised
Bollinger upper
3.27
20, 2σ
Bollinger lower
2.01
20, 2σ
50 / 200 cross
Golden
2.71 vs 1.83
Trend bias
Above 200
+18.47%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.08
More volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
51.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-62.2%
Peak to trough
Max drawdown 5Y
-91.1%
Peak to trough
ATR 14
0.14
6.58% of price
Beta (reported)
1.20
5Y monthly, from filing
Short interest
Shares short
6.21M
Prior 8.05M
Change vs prior
-22.8%
Shorts covering
% of float
15.16%
Elevated
% of shares out
8.15%
Against total outstanding
Days to cover
4.7
Liquid
Float
37.15M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 17, 26 | BTIG | MAINTAINED | Buy | Buy |
| Sep 11, 26 | B. Riley Securities | INITIATED | — | Buy |
| Sep 9, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 20, 26 | BTIG | INITIATED | — | Buy |
| Mar 19, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 6, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Mar 5, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Mar 5, 25 | Citizens Capital Markets | MAINTAINED | Market Outperform | Market Outperform |
| Aug 14, 24 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| Aug 13, 24 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 12, 24 | William Blair | DOWNGRADE | Outperform | Market Perform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-17
Periodic Financial Reports
10-Q · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-07-20
Corporate Changes & Voting Matters
8-K · 2026-06-23
Corporate Changes & Voting Matters
8-K · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Periodic Financial Reports
10-Q · 2026-05-05
Proxy Statements
DEF 14A · 2026-04-09
Headlines
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
GlobeNewswire · 29d ago
Neuronetics (STIM) Q2 2026 Earnings Call Transcript
Motley Fool · 50d ago
Neuronetics, Inc. Q2 2026 Earnings Call Summary
Moby · 57d ago
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...
GuruFocus.com · 57d ago
Neuronetics Q2 Earnings Call Highlights
MarketBeat · 57d ago
Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase
InvestorsHub · 57d ago
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 57d ago
Neuronetics: Q2 Earnings Snapshot
Associated Press · 57d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.